These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 14559824)

  • 1. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
    Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
    J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood].
    Hu Q; Zhou MX; Liu SY; Zhang LQ; Liu AQ; Guo YJ; Song Y
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):921-4. PubMed ID: 14723816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
    Singh B; Reddy PG; Goberdhan A; Walsh C; Dao S; Ngai I; Chou TC; O-Charoenrat P; Levine AJ; Rao PH; Stoffel A
    Genes Dev; 2002 Apr; 16(8):984-93. PubMed ID: 11959846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
    Grünwald V; DeGraffenried L; Russel D; Friedrichs WE; Ray RB; Hidalgo M
    Cancer Res; 2002 Nov; 62(21):6141-5. PubMed ID: 12414639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
    Chung TW; Lee YC; Ko JH; Kim CH
    Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray.
    Abbott RT; Tripp S; Perkins SL; Elenitoba-Johnson KS; Lim MS
    Mod Pathol; 2003 Jun; 16(6):607-12. PubMed ID: 12808067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
    Tanaka M; Grossman HB
    Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
    Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
    Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
    Lee S; Choi EJ; Jin C; Kim DH
    Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
    Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
    Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
    Gu L; Findley HW; Zhou M
    Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of PI3K /Akt /mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin].
    Ai YW; Yu HG; Yu JP; Yang Y; Li H; Hu XW; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):494-7. PubMed ID: 19062713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
    Kandel ES; Skeen J; Majewski N; Di Cristofano A; Pandolfi PP; Feliciano CS; Gartel A; Hay N
    Mol Cell Biol; 2002 Nov; 22(22):7831-41. PubMed ID: 12391152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
    Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.